Free EU shipping over €200 · For research use only
Reference

Retatrutide Dosage: A Reference Guide

5 min readUpdated 18 Jul 2026RetaNord Research Library

Important: the figures below are commonly cited reference ranges collected from public, widely available community and trial literature. They are not a dosing recommendation and not medical advice. RetaNord products are supplied for laboratory and in-vitro research only — not for human or veterinary use. Nothing here should be read as instruction for personal use.

The commonly cited ranges

Retatrutide is a once-weekly compound. Across public references, three loose tiers come up again and again:

  • Beginner — ~1 mg / week. A low starting point used to gauge tolerance.
  • Standard — ~4–8 mg / week. The band most often referenced after gradual titration.
  • Advanced — up to ~12 mg / week. The upper end studied in trials; far less commonly referenced.

The clinical trial programme itself escalated gradually over many weeks rather than starting at a high dose — which is the single most important pattern in the public data.

Why gradual titration is the recurring theme

The most frequently reported effects of GLP-1-class compounds — nausea, reduced appetite, GI upset — are dose-dependent. Public references almost universally describe starting low and increasing slowly, giving the body time to adjust at each step rather than jumping straight to a standard dose. A typical described pattern is a small starting amount held for several weeks before any increase.

Frequency and timing

Retatrutide's long half-life means it is referenced as a once-weekly compound, taken on the same day each week to keep levels even. This is one reason it is grouped with semaglutide and tirzepatide rather than the daily peptides.

Turning a dose into a syringe draw

A dose in milligrams is not the same as a volume in the syringe — the draw depends entirely on how much bacteriostatic water you reconstituted the vial with. More diluent means a larger, easier-to-measure draw at the same dose; less means a smaller one. Rather than doing the arithmetic by hand, use the reconstitution calculator: enter the vial (10 mg), the water volume you added, and your target figure, and it returns the exact draw in insulin-syringe units. If insulin-syringe units are unfamiliar, see insulin syringe units explained.

Why RetaNord only supplies 10 mg

Once a lyophilised peptide is reconstituted it slowly loses potency, so a larger vial would degrade before it could be used up. A 10 mg vial is sized so a reconstituted batch stays within its usable window from the first draw to the last — a deliberate quality choice. See the product page for the full spec and Certificate of Analysis.

The bottom line

Public references cluster around 1 mg up to 4–8 mg per week, once weekly, reached by slow titration — but these are reference figures for context only. RetaNord supplies documented, third-party-tested material for laboratory research; how it is handled in that setting follows your own validated protocol.

Order now